D'Argento, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 593
EU - Europa 333
AS - Asia 121
AF - Africa 12
SA - Sud America 1
Totale 1.060
Nazione #
US - Stati Uniti d'America 592
SE - Svezia 124
IT - Italia 73
CN - Cina 61
IE - Irlanda 33
SG - Singapore 26
DE - Germania 25
IN - India 25
FR - Francia 19
CI - Costa d'Avorio 12
BE - Belgio 11
GB - Regno Unito 11
FI - Finlandia 9
IR - Iran 8
RU - Federazione Russa 6
UA - Ucraina 6
RO - Romania 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
AT - Austria 2
BN - Brunei Darussalam 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
MD - Moldavia 1
MX - Messico 1
NL - Olanda 1
Totale 1.060
Città #
Chandler 171
Ashburn 45
Ann Arbor 33
Cattolica 32
Dublin 32
Boardman 21
San Mateo 21
New York 19
Redmond 19
Singapore 15
Wilmington 14
Boston 13
Abidjan 12
Dearborn 12
Princeton 12
Brussels 11
Marseille 11
Falls Church 9
Jacksonville 9
Shanghai 9
Bremen 8
Nanjing 8
Milan 7
Lawrence 5
Moscow 5
Rome 5
Fairfield 4
Redwood City 4
Shenyang 4
Andover 3
Beijing 3
Hebei 3
Helsinki 3
London 3
Los Angeles 3
Miami 3
Nanchang 3
Norwalk 3
Tianjin 3
Ardabil 2
Augusta 2
Bern 2
Brno 2
Cambridge 2
Jiaxing 2
Kish 2
Leawood 2
Mountain View 2
Paris 2
San Rafael 2
Seattle 2
Vienna 2
Woodbridge 2
Athlone 1
Atlanta 1
Bandar Seri Begawan 1
Brdo 1
Busto Arsizio 1
Cervignano del Friuli 1
Chicago 1
Chisinau 1
Chiswick 1
City of London 1
Civitanova Marche 1
Cluj-Napoca 1
Edinburgh 1
Frankfurt am Main 1
Gavirate 1
Genova 1
Groningen 1
Gunzenhausen 1
Gurgaon 1
Hangzhou 1
Hounslow 1
Houston 1
Hyderabad 1
Jinan 1
Kashan 1
Kilburn 1
Ladispoli 1
Lancaster 1
Lausanne 1
Mexico City 1
Mumbai 1
Ningbo 1
Nuoro 1
Nuremberg 1
Palermo 1
Piraeus 1
Reghin 1
Reston 1
San Diego 1
Southampton 1
Taiyuan 1
Tappahannock 1
Xian 1
Yinchuan 1
Zhengzhou 1
Totale 673
Nome #
Are TKIs favourable for the elderly with non-small-cell lung cancer? 99
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 91
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 78
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 76
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 67
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 65
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 59
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 51
Exploring the molecular and biological background of lung neuroendocrine tumours 49
Masaoka-koga and tnm staging system in thymic epithelial tumors: Prognostic comparison and the role of the number of involved structures 49
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations 48
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 48
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 47
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 45
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 44
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 43
Eficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: Case series and review of the literature 40
Collagenous colitis and atezolizumab therapy: an atypical case. 39
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 23
Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery 14
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 13
Totale 1.088
Categoria #
all - tutte 5.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202090 23 0 0 7 2 2 20 1 3 0 28 4
2020/202154 4 5 2 1 2 1 7 1 6 7 15 3
2021/2022186 26 3 1 29 10 8 2 25 9 6 22 45
2022/2023433 54 54 39 81 29 55 25 32 45 2 10 7
2023/2024217 2 59 5 9 5 23 17 14 3 12 22 46
Totale 1.088